The peptide derived from the Ig-like domain of human herpesvirus 8 K1 protein induces death in hematological cancer cells

Journal of Experimental and Clinical Cancer Research

Volumn 31, Issue 1, 2012, Pages

  Daniluk, Urszula ^a,b   Kerros, Celine ^a   Tao, Rong Hua ^a   Wise, Jillian F ^a   Ao, Xue ^a   Berkova, Zuzana ^a   Samaniego, Felipe ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CYTOTOXIC AGENT; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; LACTATE DEHYDROGENASE; PEPTIDOMIMETIC AGENT; PROTEIN K1; S20 3 PEPTIDE; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CANCER CELL; CELL CLONE; CELL DEATH; CELL KILLING; CONTROLLED STUDY; CYTOFLUOROMETRY; DAUDI CELL; ENZYMATIC ASSAY; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IN VIVO STUDY; INCUBATION TEMPERATURE; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SCID MOUSE; TUMOR XENOGRAFT;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CASPASE 8; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOLOGIC NEOPLASMS; HERPESVIRUS 8, HUMAN; HUMANS; JURKAT CELLS; MICE; MICE, SCID; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; VIRAL PROTEINS;

EID: 84865338403     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-31-69     Document Type: Article

References (36)

1. Death receptors: targets for cancer therapy. Mahmood Z, Shukla Y, Exp Cell Res 2010 316 887 899 10.1016/j.yexcr.2009.12.011 20026107
2. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Friesen C, Herr I, Krammer PH, Debatin KM, Nat Med 1996 2 574 577 10.1038/nm0596-574 8616718
3. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. Muller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, Stremmel W, Krammer PH, Galle PR, J Clin Invest 1997 99 403 413 10.1172/JCI119174 9022073
4. Resistance to CD95-mediated apoptosis of CD40-activated chronic lymphocytic leukemia B cells is not related to lack of DISC molecules expression. de Totero D, Montera M, Rosso O, Clavio M, Balleari E, Foa R, Gobbi M, Hematol J 2004 5 152 160 10.1038/sj.thj.6200362 15048066
5. Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis. Vega MI, Huerta-Yepez S, Jazirehi AR, Garban H, Bonavida B, Oncogene 2005 24 8114 8127 16103877
6. Impairment of death-inducing signalling complex formation in CD95-resistant human primary lymphoma B cells. Lajmanovich A, Irisarri M, Molens JP, Pasquier MA, Sotto JJ, Bensa JC, Leroux D, Plumas J, Br J Haematol 2004 124 746 753 10.1111/j.1365-2141.2004.04849.x 15009062
7. Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis. Plumas J, Jacob MC, Chaperot L, Molens JP, Sotto JJ, Bensa JC, Blood 1998 91 2875 2885 9531598
8. Mechanism of Fas signaling regulation by human herpesvirus 8K1 oncoprotein. Berkova Z, Wang S, Wise JF, Maeng H, Ji Y, Samaniego F, J Natl Cancer Inst 2009 101 399 411 10.1093/jnci/djn516 19276446
9. A novel antiapoptotic mechanism based on interference of Fas signaling by CD44 variant isoforms. Mielgo A, van Driel M, Bloem A, Landmann L, Gunthert U, Cell Death Differ 2006 13 465 477 10.1038/sj.cdd.4401763 16167069
10. K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis. Wang S, Maeng H, Young DP, Prakash O, Fayad LE, Younes A, Samaniego F, Blood 2007 109 2174 2182 10.1182/blood-2006-02-003178 17090655
11. A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Wang X, DeFrances MC, Dai Y, Pediaditakis P, Johnson C, Bell A, Michalopoulos GK, Zarnegar R, Mol Cell 2002 9 411 421 10.1016/S1097-2765(02) 00439-2 11864613
12. Infectious agents and lymphoma. De Falco G, Rogena EA, Leoncini L, Semin Diagn Pathol 2011 28 178 187 10.1053/j.semdp.2011.01.003 21842703
13. Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients. Cesarman E, Cancer Lett 2011 305 163 174 10.1016/j.canlet.2011.03.003 21493001
14. Programmed cell death: Apoptosis meets necrosis. Peter ME, Nature 2011 471 310 312 10.1038/471310a 21412328
15. Mechanisms of apoptosis. Reed JC, Am J Pathol 2000 157 1415 1430 10.1016/S0002-9440(10)64779-7 11073801
16. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Li H, Zhu H, Xu CJ, Yuan J, Cell 1998 94 491 501 10.1016/S0092-8674(00)81590-1 9727492
17. Resistance to Fas-mediated apoptosis in EBV-infected B cell lymphomas is due to defects in the proximal Fas signaling pathway. Snow AL, Chen LJ, Nepomuceno RR, Krams SM, Esquivel CO, Martinez OM, J Immunol 2001 167 5404 5411 11673559
18. NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells. Miller CP, Ban K, Dujka ME, McConkey DJ, Munsell M, Palladino M, Chandra J, Blood 2007 110 267 277 10.1182/blood-2006-03-013128 17356134
19. A three-dimensional model of the Fas/APO-1 molecule: cross-reactivity of anti-Fas antibodies explained by structural mimicry of antigenic sites. Fadeel B, Lindberg J, Achour A, Chiodi F, Int Immunol 1998 10 131 140 10.1093/intimm/10.2.131 9533440
20. Autocrine cell suicide in a Burkitt lymphoma cell line (Daudi) induced by interferon alpha: involvement of tumor necrosis factor as ligand for the CD95 receptor. Gisslinger H, Kurzrock R, Gisslinger B, Jiang S, Li S, Virgolini I, Woloszczuk W, Andreeff M, Talpaz M, Blood 2001 97 2791 2797 10.1182/blood.V97.9. 2791 11313273
21. Vanden Berghe T, Kroemer G: Molecular mechanisms of necroptosis: an ordered cellular explosion. Vandenabeele P, Galluzzi L, Nat Rev Mol Cell Biol 2010 11 700 714 10.1038/nrm2970 20823910
22. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules. Trentin L, Zambello R, Sancetta R, Facco M, Cerutti A, Perin A, Siviero M, Basso U, Bortolin M, Adami F, et al. Cancer Res 1997 57 4940 4947 9354461
23. Selective induction of apoptosis through activation of caspase-8 in human leukemia cells (Jurkat) by dandelion root extract. Ovadje P, Chatterjee S, Griffin C, Tran C, Hamm C, Pandey S, J Ethnopharmacol 2010 133 86 91 20849941
24. Impaired nonrestricted cytolytic activity in systemic lupus erythematosus: involvement of a pathway independent of Fas, tumor necrosis factor, and extracellular ATP that is associated with little detectable perforin. Stohl W, Elliott JE, Li L, Podack ER, Lynch DH, Jacob CO, Arthritis Rheum 1997 40 1130 1137 10.1002/art.1780400618 9182924
25. Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. Schulze-Osthoff K, Krammer PH, Droge W, EMBO J 1994 13 4587 4596 7523113
26. Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Los M, Mozoluk M, Ferrari D, Stepczynska A, Stroh C, Renz A, Herceg Z, Wang ZQ, Schulze-Osthoff K, Mol Biol Cell 2002 13 978 988 10.1091/mbc.01-05-0272 11907276
27. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. Grell M, Zimmermann G, Gottfried E, Chen CM, Grunwald U, Huang DC, Wu Lee YH, Durkop H, Engelmann H, Scheurich P, et al. EMBO J 1999 18 3034 3043 10.1093/emboj/18.11.3034 10357816
28. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA, Yuan J, Nat Chem Biol 2005 1 112 119 10.1038/nchembio711 16408008
29. Caspase-independent cell killing by Fas-associated protein with death domain. Kawahara A, Ohsawa Y, Matsumura H, Uchiyama Y, Nagata S, J Cell Biol 1998 143 1353 1360 10.1083/jcb.143.5.1353 9832562
30. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death. Lawrence CP, Chow SC, FEBS Lett 2005 579 6465 6472 10.1016/j.febslet.2005.10.041 16289096
31. Smac mimetic bypasses apoptosis resistance in FADD- or caspase-8-deficient cells by priming for tumor necrosis factor alpha-induced necroptosis. Laukens B, Jennewein C, Schenk B, Vanlangenakker N, Schier A, Cristofanon S, Zobel K, Deshayes K, Vucic D, Jeremias I, et al. Neoplasia 2011 13 971 979 22028622
32. Evidence that genetic deletion of the TNF receptor p60 or p80 inhibits Fas mediated apoptosis in macrophages. Takada Y, Sung B, Sethi G, Chaturvedi MM, Aggarwal BB, Biochem Pharmacol 2007 74 1057 1064 10.1016/j.bcp.2007.07.005 17692826
33. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. Scheurich P, Thoma B, Ucer U, Pfizenmaier K, J Immunol 1987 138 1786 1790 3029221
34. Rapid modulation of tumor necrosis factor membrane receptors by activators of protein kinase C. Scheurich P, Unglaub R, Maxeiner B, Thoma B, Zugmaier G, Pfizenmaier K, Biochem Biophys Res Commun 1986 141 855 860 10.1016/S0006-291X(86)80251-0 3026394
35. Tumor necrosis factor receptor 1 expression is upregulated in dendritic cells in patients with chronic HCV who respond to therapy. Cubillas R, Kintner K, Phillips F, Karandikar NJ, Thiele DL, Brown GR, Hepat Res Treat 2010 2010 429243 21152182
36. Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma. Saito T, Dworacki G, Gooding W, Lotze MT, Whiteside TL, Clin Cancer Res 2000 6 1351 1364 10778963